College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.

College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.

Item
http://www.wikidata.org/entity/Q47281359
The Anti-Factor Xa Range For Low Molecular Weight Heparin ThromboprophylaxisA systematic review on the accumulation of prophylactic dosages of low-molecular-weight heparins (LMWHs) in patients with renal insufficiencyGuidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolismLaboratory diagnosis of heparin-induced thrombocytopenia and monitoring of alternative anticoagulantsParenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesAppropriate enoxaparin dose for venous thromboembolism prophylaxis in patients with extreme obesity.Development of a dosing strategy for enoxaparin in obese patients.Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulation.Clinical Use of Anti-Xa Monitoring in Malignancy-Associated Thrombosis.Monitoring of anticoagulant therapy in heart disease: considerations for the current assays.Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors.Prevention and treatment of venous thromboembolism in the elderly patientCase files of the Medical Toxicology Fellowship at Banner Good Samaritan Medical Center in Phoenix, AZ: a non-warfarin anticoagulant overdose.Policies and practices in haemostasis testing among laboratories in Croatia: a survey on behalf of a Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine.Clinical Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We Getting It Right?
P2860

College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.

Item
http://www.wikidata.org/entity/Q47281359
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
College of American Pathologis ...... ted compounds, and argatroban.
@en
College of American Pathologis ...... ted compounds, and argatroban.
@nl
type
label
College of American Pathologis ...... ted compounds, and argatroban.
@en
College of American Pathologis ...... ted compounds, and argatroban.
@nl
prefLabel
College of American Pathologis ...... ted compounds, and argatroban.
@en
College of American Pathologis ...... ted compounds, and argatroban.
@nl
P1433
P1476
P2093
P304
P31
P433
P478
P577
P698
P921
P1433
P1476
College of American Pathologis ...... ated compounds, and argatroban
@en
P2093
P304
P31
P433
P478
P577
P698
P921